Showing results (281-290 of 105,852) with videos related to
Sort By:
Pageof 10,586
Antimicrobial Agents and Chemotherapy|September 15, 2010
Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia modelJared L Crandon, Joseph L Kuti, David P NicolauThe Pan African Medical Journal|November 4, 2021
Prevalence, density and predictors of malaria parasitaemia among ill young Nigerian infantsOluwatobi Faith Folarin, Bankole Peter Kuti, Akibu Oyeku OyelamiJournal of Pediatric Neurosciences|November 12, 2015
Pattern, etiological factors and determinants of mortality among sick newborns with seizures in Ilesa, NigeriaBankole Peter Kuti, Saheed Babajide Oseni, Joshua Aderinsola OwaCurrent Infectious Disease Reports|April 2, 2008
Inhaled antimicrobial therapies for respiratory infectionsShin-Woo Kim, Joseph L Kuti, David P NicolauAnnals of Clinical and Laboratory Science|July 1, 1984
Influence of methodology on glycosylated hemoglobin values in Nigerian subjects with sickle cell hemoglobinopathyA E Ohwovoriole, J A Kuti, T O JohnsonPharmacotherapy|February 24, 2007
Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004C Andrew DeRyke, Joseph L Kuti, David P NicolauSurgical Infections|October 19, 2011
Acute physiology and chronic health evaluation II score is a better predictor of mortality than IBMP-10 in patients with ventilator-associated pneumoniaDora E Wiskirchen, Joseph L Kuti, David P NicolauExpert Review of Clinical Pharmacology|December 19, 2015
Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of ResistanceMarguerite L Monogue, Joseph L Kuti, David P NicolauAntimicrobial Agents and Chemotherapy|October 21, 2015
In Vitro Pharmacodynamics of Human Simulated Exposures of Telavancin against Methicillin-Susceptible and -Resistant Staphylococcus aureus with and without Prior Vancomycin ExposureAbrar K Thabit, David P Nicolau, Joseph L KutiThe Journal of Antimicrobial Chemotherapy|February 8, 2022
Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpointsAndrew J Fratoni, David P Nicolau, Joseph L KutiPageof 10,586